Results 271 to 280 of about 100,295 (288)

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

European Urology, 2009
Johannes Witjes
exaly  

Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C

American Journal of Ophthalmology, 2020
Matthew B Schlenker, Georges M Durr, Iqbal Ike K Ahmed   +2 more
exaly  

Controlled release of Mitomycin C from modified cellulose based thermo-gel prevents post-operative de novo peritoneal adhesion

Carbohydrate Polymers, 2020
Tamanna Sultana, Byong-Taek Lee
exaly  

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Journal of Clinical Oncology, 2012
Jaffer A Ajani
exaly  

Mitomycin

Drugs, 2012
Dinesh Selva, Robert J Casson
exaly  

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

European Urology, 2016
Ottavio Chnio De Cobelli, Antoine G Van Der Heijden, Johannes Witjes   +2 more
exaly  

Mitomycin⋆

Reactions, 1986
openaire   +1 more source

Mitomycins.

Cancer chemotherapy and biological response modifiers, 1996
openaire   +3 more sources

Calreticulin exposure dictates the immunogenicity of cancer cell death

Nature Medicine, 2006
Michel Obeid, Antoine Tesniere, Francois Ghiringhelli   +2 more
exaly  

RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal

International Journal of Radiation Oncology Biology Physics, 2013
exaly